يعرض 1 - 5 نتائج من 5 نتيجة بحث عن '"Jennifer L. Goeckeler-Fried"', وقت الاستعلام: 1.53s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
  3. 3
  4. 4
  5. 5

    المساهمون: Biophysics of complex systems, Institut des Sciences Analytiques (ISA), Institut de Chimie du CNRS (INC)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut de Chimie du CNRS (INC)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS), Ctr Biomol Struct & Org, University of Maryland [College Park], University of Maryland System-University of Maryland System, Ctr Neutron Res, National Institute of Standards and Technology [Gaithersburg] (NIST), Department of Biology - Institute of Technology, Technion - Israel Institute of Technology [Haifa], We thank George H. Lorimer and Arnon Henn for access to their fluorimeters, Ananya Majumdar for help with setting up triple-resonance NMR experiments, Rajesh Singh for the Rub1 sample, Allan Weissman for RCC4 cells, and Konstantin Berlin for useful discussions. The project has been funded in part from the NCI Initiative for Chemical Genetics, NIH, under contract no. N01-CO-12400 to Stuart L. Schreiber, by NIH grants GM065334 to D.F. and GM095755 to D.F. and M.H.G., ISF grant 909-14 to M.H.G., and by NIH grants GM075061 and DK079307 and by Cystic Fibrosis Foundation Therapeutics grant BRODSK13XXO to J.L.B., and a Fulbright postdoctoral fellowship to M.A.N., and utilized NMR instrumentation supported in part by NSF grant DBI1040158 and neutron-scattering facilities supported in part by the NSF under agreement no. DMR-0944772. R.J.D. is a founder and shareholder of Cleave Biosciences, which is developing drugs that target the ubiquitin system., Technion-Israel Institute of Technology

    المصدر: Structure
    Structure, Elsevier (Cell Press), 2017, 25 (12), pp.1839-1855.e11. ⟨10.1016/j.str.2017.10.007⟩

    وصف الملف: application/pdf